Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Noticias
Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in immune cells that, when bl…
Pulmonary fibrosis: Study targets proteins to reverse lung scarring
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in immune cells that, when blocked, could significantly …
Stopping asthma in its tracks
New therapeutic ‘cocktails’ may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Scientists identify a new cancer immunotherapy target: Dysfunctional B cells
Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood — known as the tertiary lymphoid structure — where they become frustratingly dysfunctional when in close contact with tumors.
Key immune differences that make one West African ethnic group less susceptible to malaria identified
A team of researchers at NYU Abu Dhabi has uncovered how genetic and lifestyle factors influence immune responses to malaria in children from two large West African ethnic groups. The study found that children from the Fulani group have a distinct immu…
Jumbled proteins paint a bold target on the backs of brain tumors
Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue. Now, researchers at UC San Francisco have found that some cancers, like deadly brain cancer (glioma…
New therapeutic ‘cocktails’ may provide long-lasting relief for treatment-resistant asthma, other inflammatory diseases
Current asthma treatments don’t work in all patients, and they don’t provide long-term relief from potentially deadly asthma attacks.
Dysfunctional B cells: A novel target for cancer immunotherapy and diagnostics
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood—known as the tertiary lymphoid structure—where they be…
Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I (RIG-I) agonist RNA (RAR) induces innate immune signaling and death of hepatocellular carcinoma cells in vitro.